CR9323A - THIAZOLIDINONES AS INHIBITORS OF POLOQUINASES (Plk) AS A MEDICINAL PRODUCT - Google Patents

THIAZOLIDINONES AS INHIBITORS OF POLOQUINASES (Plk) AS A MEDICINAL PRODUCT

Info

Publication number
CR9323A
CR9323A CR9323A CR9323A CR9323A CR 9323 A CR9323 A CR 9323A CR 9323 A CR9323 A CR 9323A CR 9323 A CR9323 A CR 9323A CR 9323 A CR9323 A CR 9323A
Authority
CR
Costa Rica
Prior art keywords
thiazolidinones
plk
inhibitors
poloquinases
medicinal product
Prior art date
Application number
CR9323A
Other languages
Spanish (es)
Inventor
Schulze Volker
Eis Knut
Wortmann Lars
Kosemund Dirk
Prien Olaf
Siemeister Gerhard
Hess-Stumpp Holger
Eberspaecher Uwe
O Arnaiz Damian
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102005005395A external-priority patent/DE102005005395A1/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CR9323A publication Critical patent/CR9323A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencion se relaciona con tiazolidinonas de la formula general (I) y su preparacion y su uso como inhibidores de la quinasa Polo Like (Plk), para el tratamiento de distintas enfermedades.The invention relates to thiazolidinones of the general formula (I) and their preparation and use as inhibitors of the Polo Like kinase (Plk), for the treatment of various diseases.

CR9323A 2005-02-03 2007-08-17 THIAZOLIDINONES AS INHIBITORS OF POLOQUINASES (Plk) AS A MEDICINAL PRODUCT CR9323A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005005395A DE102005005395A1 (en) 2005-02-03 2005-02-03 New thiazolidinone compounds are polo-like kinase inhibitors, useful for treating e.g. cancer, autoimmune diseases, cardiovascular diseases, infectious diseases, nephrological diseases and viral diseases
US65123205P 2005-02-10 2005-02-10

Publications (1)

Publication Number Publication Date
CR9323A true CR9323A (en) 2008-02-21

Family

ID=38481436

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9323A CR9323A (en) 2005-02-03 2007-08-17 THIAZOLIDINONES AS INHIBITORS OF POLOQUINASES (Plk) AS A MEDICINAL PRODUCT

Country Status (4)

Country Link
KR (1) KR20070100830A (en)
CR (1) CR9323A (en)
IL (1) IL185023A0 (en)
NO (1) NO20074448L (en)

Also Published As

Publication number Publication date
NO20074448L (en) 2007-10-31
KR20070100830A (en) 2007-10-11
IL185023A0 (en) 2007-12-03

Similar Documents

Publication Publication Date Title
UY29264A1 (en) METAS REPLACED THIAZOLIDINONES, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT
PA8772101A1 (en) IMIDAZOL-TRIAZOLOPIRIMIDINAS REPLACED
UY30578A1 (en) NEW DERIVATIVES OF 2,4 ?? - AND 3, 4 ?? - BIPIRIDINA SUBSTITUTED, PROCEDURES FOR THEIR PREPARATION, MEDICINES CONTAINING THEM AND APPLICATIONS
GT200500363A (en) 3-AMINO-PIRAZOL [3,4B] PIRIDINES WITH PROTEINTIROSINKINASE INHIBITORS, THEIR PREPARATION AND USE AS A MEDICINAL PRODUCT.
PA8660301A1 (en) PIRAZOLO PIRIDINAS REPLACED, COMPOSITIONS THAT CONTAIN THEM, MANUFACTURING AND USE PROCEDURE
UY31484A1 (en) HETEROARIL-SUBSTITUTED PIPERIDINS
UY30779A1 (en) USED DIHYDROPIRIDINE DERIVATIVES AS INHIBITORS OF PROTEIN QUINASE
ECSP066717A (en) SUBSTITUTED QUINOLINE COMPOUNDS
DOP2006000024A (en) THIAZOLIDINONES, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT
UY27714A1 (en) 2 - HETEROARIL - CDK INHIBITING PYRIMIDINES, ITS PREPARATION AND ITS USE AS MEDICATIONS.
UY30500A1 (en) AZABENCIMIDAZOLILO COMPOUNDS
BR122019010008B8 (en) pyrimidine derivatives, their use, and pharmaceutical composition and combination
GT200900095A (en) REPLACED DIHYDROPIRAZOLONES FOR THE TREATMENT OF CARDIOVASCULAR AND HERMATOLOGICAL DISEASES.
BRPI0514731A (en) pyrimidine derivatives
UY30328A1 (en) DERIVATIVES OF 2-PIRIDONA, PREPARATION PROCESSES, COMPOSITIONS CONTAINING THEM AND APPLICATIONS.
UY29414A1 (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
CU20110088A7 (en) ANILINA-PYRIMIDINE DERIVATIVES SUBSTITUTED WITH SULFOXIMINE AS INHIBITORS OF CYCLINE-DEPENDENT KINASE (CDK), PRODUCTION AND USE OF THE SAME AS MEDICINAL PRODUCTS
CU20100111A7 (en) 4- (4-CIANO-2-TIOARIL) DIHYDROPIRIMIDINONES AND ITS USE FOR THE TREATMENT AND PREVENTION OF PULMONARY AND CARDIOVASCULAR DISEASES
CO6630193A2 (en) Inhibitors of selected tyrosine kinase protein activity
UY31016A1 (en) NEW NITROGEN HETEROCICLIC COMPOUNDS, ITS PREPARATION AND ITS USE AS ANTIBACTERIAL MEDICINES
DOP2006000280A (en) NEW SUBSTITUTED ACYCLIC FUROPIRIMIDINE DERIVATIVES AND THEIR USE
UY29189A1 (en) NONADEPSIPEPTIDES ACILATED II
UY28313A1 (en) NONADEPSIPEPTIDOS ACILADOS
DE502005005652D1 (en) Heterocyclic sub-substituted nononepipepidites
GT200800066A (en) DERIVATIVES OF 9-CHLORINE-15-DEOXIPROSTAGLANDIN, PROCEDURE FOR PREPARATION AND USE AS A MEDICINAL PRODUCT.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)